Company Filing History:
1 out of 141 
1 out of 3,222 
Years Active: 2014
Title: Celebrating the Innovations of Ivan Bosanac
Introduction: Ivan Bosanac, an accomplished inventor based in San Mateo, California, has made significant contributions to the field of biomedical research. With one patent to his name, Bosanac's work primarily focuses on the treatment and diagnosis of cancer, showcasing his dedication to advancing medical science.
Latest Patents: Bosanac holds a patent for the "Variant Hhip1 protein and methods and uses thereof." This innovative invention relates to derivatives of Hhip1 and presents methods for utilizing these derivatives in the treatment and diagnosis of cancer in mammals. This patent exemplifies his commitment to developing viable solutions against one of humanity's most challenging health issues.
Career Highlights: Throughout his career, Ivan Bosanac has gained valuable experience working in esteemed organizations such as Curis, Inc. and Genentech, Inc. These companies are known for their cutting-edge research in biotechnology and pharmaceuticals, providing him with a solid foundation in developing therapeutic solutions.
Collaborations: In his journey as an inventor, Bosanac has collaborated with notable colleagues, including Sarah G. Hymowitz and Robert A. Lazarus. These partnerships highlight the collaborative spirit prevalent in the research community, emphasizing how teamwork can propel the development of innovative medical technologies.
Conclusion: Ivan Bosanac has established himself as a distinguished inventor with a focus on biomedical innovation. His patent related to the Hhip1 protein stands as a testament to his dedication to cancer research and his desire to develop effective treatment methods. Through his career and collaborations, Bosanac continues to contribute to advancements in health, inspiring the next generation of innovators.